ACUREON Pharmaceuticals is a United States Biopharmaceutical Company primarily focused on specialty therapeutics to improve patient outcomes in the hospital areas of Infectious Diseases, Transplant, and ICU. To address the needs of the market, Acureon Pharma is focused on exploring opportunities that selectively acquire and enhance the market potential of novel and commercially available therapeutics and late-stage development drugs. Acureon Pharma is backed by Domain Associates, New Enterprise Associates and Alta Partners. The company is located in the western suburbs of Philadelphia.